HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

S Hollenbach Selected Research

CT52923

9/2001Efficacy of the novel selective platelet-derived growth factor receptor antagonist CT52923 on cellular proliferation, migration, and suppression of neointima following vascular injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


S Hollenbach Research Topics

Disease

1Venous Thrombosis (Deep-Vein Thrombosis)
09/2001
1Thrombosis (Thrombus)
09/2001
1Vascular System Injuries
09/2001
1Neointima
09/2001
1Carotid Artery Injuries
09/2001

Drug/Important Bio-Agent (IBA)

13- (5- nitrofuryl)- 7- (5- nitrofurfurylidene)- 3,3a,4,5,6,7- hexahydro- 2H- indazoleIBA
09/2001
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
09/2001
1CT52923IBA
09/2001

Therapy/Procedure

1Intravenous Administration
09/2001
1Oral Administration
09/2001